NextCure, Inc.
NASDAQ: NXTC
$1.24
+$0.04 (+3.3%)
Closing price December 4, 2023
Friday's top analyst upgrades and downgrades included Autodesk, Costco, Gap, Interactive Brokers, SBA Communications, Smith & Wesson, Western Digital and Zscaler.
Published:
NextCure updated clinical results from its early stage cancer study at the Society for Immunotherapy of Cancer annual meeting. As a result, NextCure shares were crushed on Monday.
Published:
Last Updated:
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
Published:
Last Updated: